The role of active surveillance for Bethesda III/IV thyroid nodules and the differential risk associated with nuclear atypia in Bethesda III category cytology

被引：0
|
作者：
Collins, Jennifer [1 ]
Takhar, Arunjit [1 ]
Brunet, Aina [1 ]
Moonim, Mufaddal [1 ]
Gill-Barman, Baljit [1 ]
Chandra, Ashish [1 ]
Simo, Ricard [1 ]
Jeannon, Jean-Pierre [1 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, London, England
来源：
ORAL ONCOLOGY | 2021年 / 118卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-198
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk Stratification of Bethesda III Category Thyroid Nodules
    Alseddeeqi, Eiman
    Mubarak, Rawia
    Altinoz, Ajda
    More, Yogesh
    Elomami, Abdulghani
    [J]. JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 9 (06) : 180 - 185
  • [2] Risk Stratification of Thyroid Nodules Diagnosed as Bethesda Category III by Ultrasound, Size, and Cytology
    Ahn, Hye Shin
    Na, Dong Gyu
    Kim, Ji-Hoon
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2024, 25 (10) : 924 - 933
  • [3] Importance of cytological subclassification of thyroid nodules with Bethesda category III cytology (AUS/FLUS) into architectural atypia only and nuclear atypia: A prospective study
    Rosario, Pedro Weslley
    Calsolari, Maria Regina
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2017, 45 (07) : 604 - 607
  • [4] Malignant risk of pediatric Bethesda category III thyroid nodules subcategorized by nuclear atypia and other: A single institution experience
    Jin, Xiaobing
    Jing, Xin
    Smola, Brian
    Heider, Amer
    [J]. CANCER CYTOPATHOLOGY, 2024,
  • [5] Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups
    Garcia Pascual, Luis
    Lluisa Surralles, Maria
    Morlius, Xavier
    Garcia Cano, Laia
    Gonzalez Minguez, Clarisa
    [J]. ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 (10): : 577 - 583
  • [6] Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
    Liu, Xiaoli
    Wang, Jingjing
    Du, Wei
    Dai, Liyuan
    Fang, Qigen
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Evaluation of thyroid nodules classified as Bethesda category III on FNAC
    Garg, Shiwani
    Naik, Leena P.
    Kothari, Kanchan S.
    Fernandes, Gwendolyn C.
    Agnihotri, Mona A.
    Gokhale, Jagruti C.
    [J]. JOURNAL OF CYTOLOGY, 2017, 34 (01) : 5 - 9
  • [8] Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
    Turkdogan, Sena
    Pusztaszeri, Marc
    Forest, Veronique-Isabelle
    Hier, Michael P.
    Payne, Richard J.
    [J]. CANCERS, 2020, 12 (09) : 1 - 8
  • [9] Performance of Afirma genomic sequencing classifier and histopathological outcome are associated with patterns of atypia in Bethesda category III thyroid nodules
    Jin, Xiaobing
    Lew, Madelyn
    Pantanowitz, Liron
    Smola, Brian
    Jing, Xin
    [J]. CANCER CYTOPATHOLOGY, 2022, 130 (11) : 891 - 898
  • [10] Performance of Afirma Genomic Sequencing Classifier and Histopathological Outcome Are Associated with Subtype of Atypia in Bethesda Category III Thyroid Nodules
    Jin, Xiaobing
    Lew, Madelyn
    Smola, Brian
    Pantanowitz, Liron
    Jing, Xin
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 263 - 264
12345